To further investigate the role of miR-454 in ovarian cancer, we examined the effect of miR-454 on activation of the Akt/mTOR and Wnt/β-catenin signaling pathways in ovarian cancer cells. This evidence concerns the gene AKT1 and ovarian carcinoma.